| # | Drug | Count |
|---|---|---|
| 0 | PANITUMUMAB | 43 |
| 1 | FLUOROURACIL | 32 |
| 2 | FLUOROURACIL CREAM, 0.5% | 32 |
| 3 | OXALIPLATIN | 32 |
| 4 | OMEPRAZOLE MAGNESIUM | 27 |
| 5 | CAPECITABINE | 23 |
| 6 | OMEPRAZOLE | 21 |
| 7 | BEVACIZUMAB | 19 |
| 8 | DEXAMETHASONE | 19 |
| 9 | DEXAMETHASONE 1.5 MG | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METYROSINE | 1 | 0.0123 |
| 1 | TRIMIPRAMINE MALEATE | 4 | 0.0101 |
| 2 | PHENTOLAMINE MESYLATE | 1 | 0.0062 |
| 3 | L-GLUTAMINE | 1 | 0.0028 |
| 4 | PANITUMUMAB | 43 | 0.0027 |
| 5 | TRASTUZUMAB-QYYP | 1 | 0.0026 |
| 6 | MIGLITOL | 2 | 0.0021 |
| 7 | BETHANECHOL CHLORIDE | 1 | 0.0018 |
| 8 | SORBITOL | 1 | 0.0017 |
| 9 | GADOTERIDOL | 3 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catecholamine Synthesis Inhibitor [EPC] | 1 | 0.0123 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 46 | 0.0010 |
| 2 | Paramagnetic Contrast Agent [EPC] | 4 | 0.0009 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |
| 6 | Tetracycline-class Antibacterial [EPC] | 3 | 0.0004 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 8 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 9 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |